TipRanks on MSN
Abivax announces patient-reported outcomes from ABTECT trial
Abivax (ABVX) announced patient-reported outcomes from its Phase 3 ABTECT 8-week induction trials evaluating obefazimod in adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback